Skip to content

Prospective study for maternal perinatal drug exposure associated with birth defects in offspring

Prospective study for maternal perinatal drug exposure associated with birth defects in offspring

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022569
Enrollment
Unknown
Registered
2019-04-17
Start date
2018-08-01
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

birth defects

Interventions

Case series:Nil

Sponsors

Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women less than 14 gestational weeks

Exclusion criteria

Exclusion criteria: Pregnant women more than 14 gestational weeks

Design outcomes

Primary

MeasureTime frame
Birth defects in clinical diagnosis;

Countries

China

Contacts

Public ContactWang Yanping

Sichuan University

wyxyanping@163.com+86 18180609095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026